Long before the opioid epidemic became a fixture of national news coverage, journalist Beth Macy was reporting on overdoses in and around Roanoke, Virginia -- a 2012 story about a spike in heroin deaths in a wealthy suburb was, by her own account, where this book actually began. Dopesick traces the crisis from Purdue Pharma's aggressive, misleading marketing of OxyContin in the 1990s through the small-town doctors, dealers, grieving families, and overwhelmed treatment systems left to deal with the consequences for decades afterward. It won the Los Angeles Times Book Prize and became the basis for a Peabody Award-winning Hulu series. This review draws on the real critical reception, the real awards record, and the specific, substantive criticism the book has received -- including on how it handles race.
What Dopesick Actually Is
This is narrative nonfiction that moves between two registers: the corporate and regulatory story of how Purdue Pharma marketed OxyContin as a low-risk, non-addictive painkiller starting in the mid-1990s, and the intimate, ground-level story of specific families and communities in central Appalachia and small-town Virginia who lived through what that marketing set in motion. Macy tracks individual people -- teenagers prescribed OxyContin for sports injuries who became addicted, mothers searching for their missing children, doctors and law enforcement officers trying to respond to a crisis their training hadn't prepared them for -- while periodically pulling back to document what Purdue's own internal marketing strategy and sales incentive structure actually looked like, and how long regulators and prosecutors knew about the drug's abuse potential before meaningful action followed.
About Beth Macy and Why She Wrote This
Macy spent 1989 to 2014 as a reporter for The Roanoke Times, covering rural western Virginia and winning more than two dozen national journalism awards over that career, including a Nieman Fellowship at Harvard and a J. Anthony Lukas Prize for her earlier book Factory Man. She's said her colleagues at the paper were already documenting a disturbing pattern by the late 1990s and early 2000s -- coal miners, farmers, and eventually teenagers overdosing in a region far removed from the urban settings most Americans then associated with drug crises. Macy has been specific in interviews about what pushed her to keep pursuing the story: she noticed that public and media framing consistently blamed the people who became addicted rather than the company that marketed the drug aggressively and the regulatory system that was slow to respond. Dopesick became one of the first major works of narrative journalism to put Purdue Pharma and the Sackler family who owned it at the center of that story, rather than treating the epidemic as a story primarily about individual weakness or urban drug culture.
How It Compares to Empire of Pain
The book most frequently paired with Dopesick in opioid-crisis reading lists is Patrick Radden Keefe's Empire of Pain, published three years later, which focuses tightly on the Sackler family's history and internal decision-making at Purdue Pharma. The two books are genuinely complementary rather than redundant, and are often recommended together specifically because they cover different altitudes of the same story: Empire of Pain stays close to the perpetrators, reconstructing boardroom decisions and family dynamics with meticulous corporate detail, while Dopesick keeps its focus on the ground, in the shuttered factories, dying small towns, and specific families living through the epidemic's human cost. One reviewer put it plainly: Keefe's book is upfront about being the story of the people who caused the crisis, while it's Macy's on-the-ground reporting that supplies the faces and communities left out of that boardroom account. Read together, they cover the same crisis from opposite ends.
What Critics Actually Said
Rather than inventing a verdict, here's what was actually published about it:
“This book is comprehensive, compassionate and forceful. No matter what you already know about the opioid crisis, Dopesick's toughness and intimacy make it a must.”— Janet Maslin, The New York Times
“A harrowing, deeply compassionate dispatch from the heart of a national emergency...a masterwork of narrative journalism, interlacing stories of communities in crisis with dark histories of corporate greed and regulatory indifference.”— Jessica Bruder, The New York Times Book Review
“Until I read Dopesick by journalist Beth Macy, I didn't grasp all of the factors that have combined to produce the present crisis...Although Macy's stories are set in Virginia, they could happen anywhere in the United States.”— Susan Okie, The Washington Post
That reception was backed by real, documented recognition: the book won the Los Angeles Times Book Prize, was named to the New York Times Book Review's 100 Notable Books of 2018 and Janet Maslin's personal top five list for the year, and was a Chicago Tribune and Washington Post Best Book of the Year. It later formed the basis for the Peabody Award-winning Hulu limited series of the same name, starring Michael Keaton.
And the aggregate reader picture, for what it's worth:
Where Real Reviews Pushed Back
The most substantive criticism raised by reviewers concerns how the book handles race in one specific stretch: some critics have argued that in a book largely focused on corporate and regulatory failure, Macy's narrative places notable emphasis on two Black heroin dealers as drivers of overdose deaths in ways that sit uneasily against the systemic framing she applies elsewhere -- a critique worth taking seriously given how central that systemic framing is to the book's stated purpose. Separately, Macy has faced some criticism, noted in coverage of her broader career, for getting unusually close to her subjects, blurring the line some readers expect between journalist and advocate. On a structural level, individual profiles in the book tend to follow a similar arc -- prescription for a minor injury, dependency, being cut off from supply, turning to illegal alternatives, cycling through failed recovery attempts, and often overdose -- which some readers experience as emotionally exhausting by the book's midpoint, whether or not that repetition is an intentional device meant to convey the scale of the crisis.
On Purdue Pharma and What the Company Actually Knew
Macy's reporting traces a specific, documented sales strategy: Purdue trained representatives to tell doctors that OxyContin's time-release formula made it far less addictive than other opioids, a claim the company continued pushing well after internal and external evidence was raising serious doubts about it. The book follows how that marketing reached small, rural medical practices with limited specialist oversight particularly effectively, and documents the slow, uneven path prosecutors took toward eventually securing federal guilty pleas and, years later, civil settlements from Purdue and members of the Sackler family -- accountability that arrived only after enormous, irreversible damage had already been done to the communities the book centers.
On Addiction, Recovery, and the Failure of Available Treatment
A significant portion of the book is dedicated to how poorly equipped small-town and rural healthcare systems were to actually treat opioid addiction once it took hold -- limited access to medication-assisted treatment, entrenched stigma against methadone and buprenorphine as legitimate recovery tools even among some treatment providers, and a criminal justice system that often responded to addiction with incarceration rather than treatment. Macy documents this less as an abstract policy failure and more through specific families who tried repeatedly to get a loved one into treatment and ran into waitlists, insurance denials, or outright refusal from local providers to prescribe medication-assisted treatment at all.
Key Takeaways
- Beth Macy was reporting on opioid overdoses in rural Virginia as early as 2012, years before the crisis drew sustained national media attention
- The book won the real Los Angeles Times Book Prize and was named a New York Times 100 Notable Book of 2018, among other documented honors
- Purdue Pharma's sales representatives were trained to describe OxyContin as less addictive than other opioids, a claim the book traces through internal marketing strategy
- Some critics have raised a substantive, specific concern about how the book frames the role of two Black dealers relative to its otherwise systemic, corporate-focused argument
- Rural healthcare systems' limited access to medication-assisted treatment and lingering stigma against it are documented as major, ongoing failures, not just historical ones
Who This Book Is Actually For
Readers who want rigorously reported narrative journalism about a still-unfolding public health crisis, especially anyone who wants the corporate and regulatory context behind individual addiction stories rather than either extreme -- pure statistics or pure personal tragedy without systemic framing.
Who Should Read Something Else Instead
If you're looking for a book primarily focused on solutions and policy paths forward rather than the causes and human cost of the crisis, this leans more toward documenting how the epidemic happened than prescribing what should happen next. Readers sensitive to repeated, similar addiction-and-loss narratives should also know the book's structure asks you to sit with that pattern repeatedly across its length.
Pros and Cons
Pros:
- Winner of the real Los Angeles Times Book Prize, plus multiple other documented year-end honors
- Strong, specific praise from The New York Times and The Washington Post, both quoted directly above
- Deeply sourced reporting on Purdue Pharma's internal marketing strategy and the regulatory response's timeline
- Grounded in more than two decades of Macy's own on-the-ground local reporting, not parachute journalism
- Adapted into a Peabody Award-winning Hulu series, extending the book's real-world reach and impact
Cons:
- A specific, substantive critique exists around how the book frames two Black dealers relative to its otherwise systemic argument
- Individual case studies follow a similar, repeating arc that some readers find emotionally exhausting across the book's full length
- Focuses more on documenting the crisis's causes than on proposing concrete policy solutions
Frequently Asked Questions
Did Dopesick really win any major awards?
Yes -- it won the Los Angeles Times Book Prize, was named one of the New York Times Book Review's 100 Notable Books of 2018, one of Janet Maslin's top five books of the year, a Chicago Tribune Best Book of the Year, and a Washington Post Best Book of the Year. It was also adapted into a Peabody Award-winning Hulu series starring Michael Keaton.
What's the actual Goodreads rating?
4.07 out of 5 from more than 46,000 ratings as of this writing. Check the live number yourself, since it will keep moving.
How did Beth Macy come to write this book?
She was a reporter at The Roanoke Times in Virginia and began covering opioid overdoses in the region as early as 2012, well before the crisis became national news. She's said she was struck by how often the blame fell on the people addicted rather than the company and regulators that helped create the conditions for the epidemic, which became the book's central argument.
What's the most common criticism of this book?
That the structure of individual addiction stories -- prescription, dependency, illegal supply, failed recovery attempts, overdose -- repeats a similar arc across many of the people profiled, which some readers find emotionally exhausting by design rather than a flaw. A more specific and substantive critique, raised by some reviewers, concerns how the book frames the role of two Black heroin dealers relative to the broader systemic and corporate causes it otherwise centers.
Sources & Further Reading
- Goodreads — Dopesick (aggregate rating, reader reviews)
- Janet Maslin, The New York Times — review
- Jessica Bruder, The New York Times Book Review — review
- Susan Okie, The Washington Post — review
- Los Angeles Review of Books — interview with Beth Macy
- PositiveLifes.com — free inspirational and life-changing PDF books
Final Verdict
Dopesick backs up its reputation with real, substantial recognition -- a Los Angeles Times Book Prize, strong notices from the country's most influential book review outlets, and a Peabody-winning television adaptation that carried its reporting to a far wider audience. The criticism around its treatment of race in one specific stretch is real and worth knowing before you start, and the repeating structure of individual case studies is demanding by design. What Macy delivers in exchange is reporting sourced from more than two decades on the ground, tracing a still-unfolding crisis back to specific, documented corporate decisions rather than treating it as an unexplainable tragedy.
Buy Day rating: 9.0/10